Fritextsökning
Innehållstyper
-
Medicon Village Science Park
-
Bio-Works
-
Achieve Efficient, Fast Targeting of Your Sample
Step into the future of imaging technology with VersaXRM 730.
-
Come see us at the upcoming events!
We have some upcoming events where you can see our latest products live!
-
Advancing 3D Culture Imaging: Insights from Academia, Biotech, and Pharma
Webinar | March 13, 2024, 12 PM EST.
-
Anna Törner: Yes, I Am Sick, But Not Weak
”People often say that someone who is ill only has one wish—to get better. But I think that is not true. Someone who is ill also longs to be understood, to be r...
-
Från apotekare till poddare – Magnus Lejelöv har rösten som verktyg
Magnus Lejelöv har över 20 års erfarenhet från läkemedelssektorn och har intervjuat nära två hundra vårdprofiler i sina poddar. I maj står han på scenen i Lund ...
-
The investor: “The major common diseases are hot again”
She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of ...
-
Danish biotech to buy struggling American oncology company
Danish drugmaker Pharmacosmos has agreed to acquire American pharmaceutical company G1 Therapeutics in a deal that amounts to 405 million dollars.
-
Pharma Relations AB
-
BD separerar affärsområdet Biosciences – fokuserar på medtech
BD slimmar portföljen och avyttrar affärsområdena bioscience och diagnostik. “Nya BD” ska bli ett helgjutet medicinteknikföretag.
-
Hajpat genterapibolag går för en spottstyver
Genterapibolaget Bluebird Bio värderades en gång till över 10 miljarder dollar – men säljs nu för en bråkdel av den summan.
-
Festo AB
-
SMC lanserar ny elektrisk cylinder för livsmedelsindustrin
Nya HF2A-LEY är framtagen för att möta kraven inom livsmedelsindustrin och passar perfekt i maskiner som utsätts för regelbunden desinfektion och rengöring. Cyl...
-
Quotient Sciences Limited
-
The US is leaving the WHO
The newly installed US President, Donald Trump, has issued an executive order for the US to leave the World Health Organization, WHO.
-
Affibody AB
-
Lonza
-
Galenica AB
-
Italian pharmaceutical company buys rights to immunotherapy from Sanofi
Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).
-
Optimize Your Visibility
ZEISS presents our newest VersaXRM® 730 3D X-ray microscope.
-
A modular system for precise and automated cell dispensing
How the benefits of laboratory automation can be combined with gentle cell handling.
-
Norwegian cancer research companies merge
The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.
-
Emerson